Literature DB >> 16137611

Transforming growth factor beta (TGF-beta) and autoimmunity.

Christopher A Aoki1, Andrea T Borchers, Ming Li, Richard A Flavell, Christopher L Bowlus, Aftab A Ansari, M Eric Gershwin.   

Abstract

TGF-beta1 deficient mice develop multifocal inflammatory autoimmune disease and serve as a valuable animal model of autoimmunity. Transgenic expression of a dominant negative form of TGF-beta receptor type II in T cells have enabled the study of cell lineage specific effects of TGF-beta providing clues to the potential etiology of autoimmunity. These studies suggest that TGF-beta deficiency may induce autoimmune disease by influencing a number of immunological phenomena including lymphocyte activation and differentiation, cell adhesion molecule expression, regulatory T cell function, the expression of MHC molecules and cytokines, and cell apoptosis. The spectrum of effects appears to be significant in mucosal immunity and may contribute to the pathogenesis of inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16137611     DOI: 10.1016/j.autrev.2005.03.006

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  35 in total

1.  Cancer-derived matrix metalloproteinase-9 contributes to tumor tolerance.

Authors:  Bin-Quan Wang; Chun-Ming Zhang; Wei Gao; Xu-Feng Wang; Hai-Li Zhang; Ping-Chang Yang
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-11       Impact factor: 4.553

Review 2.  Modulation of glomerulosclerosis.

Authors:  Li-Jun Ma; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2007-09-08       Impact factor: 9.623

3.  A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.

Authors:  Yasmina Bauer; John Tedrow; Simon de Bernard; Magdalena Birker-Robaczewska; Kevin F Gibson; Brenda Juan Guardela; Patrick Hess; Axel Klenk; Kathleen O Lindell; Sylvie Poirey; Bérengère Renault; Markus Rey; Edgar Weber; Oliver Nayler; Naftali Kaminski
Journal:  Am J Respir Cell Mol Biol       Date:  2015-02       Impact factor: 6.914

4.  Enhancing Adoptive Cell Therapy of Cancer through Targeted Delivery of Small-Molecule Immunomodulators to Internalizing or Noninternalizing Receptors.

Authors:  Yiran Zheng; Li Tang; Llian Mabardi; Sudha Kumari; Darrell J Irvine
Journal:  ACS Nano       Date:  2017-03-01       Impact factor: 15.881

Review 5.  Cytokine Signaling in the Development and Homeostasis of Regulatory T cells.

Authors:  Kevin H Toomer; Thomas R Malek
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-03-01       Impact factor: 10.005

Review 6.  The role of TGF-beta signaling in dendritic cell tolerance.

Authors:  Grace E Esebanmen; William H R Langridge
Journal:  Immunol Res       Date:  2017-10       Impact factor: 2.829

7.  Transforming Growth Factor β1/SMAD Signaling Pathway Activation Protects the Intestinal Epithelium from Clostridium difficile Toxin A-Induced Damage.

Authors:  Christianne Maria Tinoco-Veras; Ana Angélica Q A Santos; Joice Stipursky; Marcelo Meloni; Ana Paula Bérgamo Araujo; Danielle Abreu Foschetti; Diana López-Ureña; Carlos Quesada-Gómez; Renata F C Leitão; Flávia Carvalho Alcantara Gomes; Gerly Anne de Castro Brito
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

8.  The effects of tacrolimus ointment on regulatory T lymphocytes in atopic dermatitis.

Authors:  Marzia Caproni; Daniele Torchia; Emiliano Antiga; Walter Volpi; Elena del Bianco; Paolo Fabbri
Journal:  J Clin Immunol       Date:  2006-06-14       Impact factor: 8.317

9.  Targeting small molecule drugs to T cells with antibody-directed cell-penetrating gold nanoparticles.

Authors:  Yu-Sang Sabrina Yang; Kelly D Moynihan; Ahmet Bekdemir; Tanmay M Dichwalkar; Michelle M Noh; Nicki Watson; Mariane Melo; Jessica Ingram; Heikyung Suh; Hidde Ploegh; Francesco R Stellacci; Darrell J Irvine
Journal:  Biomater Sci       Date:  2018-12-18       Impact factor: 6.843

10.  Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes.

Authors:  Paul Ashwood; Amanda Enstrom; Paula Krakowiak; Irva Hertz-Picciotto; Robin L Hansen; Lisa A Croen; Sally Ozonoff; Isaac N Pessah; Judy Van de Water
Journal:  J Neuroimmunol       Date:  2008-11-15       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.